Join us for an exclusive event dedicated to exploring the upcoming KCE Health Economics (HE) Guidelines for 2025. Discover how these guidelines address key uncertainties and their implications for healthcare decision-making at national and international levels.

Program:

• 15u00-15u10: Welcome & introduction
• 15u10-15u40: The new KCE Health Economics guidelines – Mattias Neyt, Senior Expert, KCE
• 15u40-16u00: Global and EU perspective on the guidelines – Glenn Philips, Global Head VP, Health Economics & Outcome Research, ArgenX
• 16u00-16u50: Panel debate and Q&A with Mattias Neyt (KCE), Glenn Philips (ArgenX), Sebastian Vermeersch (Hict) and Joël Daems (RIZIV-INAMI)
• 16u50-17u00: Conclusions

Followed by a networking drink.

Don’t miss this opportunity to engage with leading experts in health economics. Register now and be part of shaping the future of healthcare decision-making.

👉  If you have questions about this topic that you would like to see addressed during the session, please fill out this form.

___________________________________________________________________________________

Healixia has established a Market Access working group since 2025, in response to interest from our members. With this initiative, we aim to strengthen our members professionally by offering training and networking opportunities on different relevant Market Access topics.

We would like to capture which topics are most relevant to Market Access professionals. This will help us tailor our initiatives to the needs and interests of our members. Click here to share your opinion on the most relevant Market Access topics for future sessions.